Nachrichten zur Eli Lilly & Co. Aktie

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…

World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna

…

Tech roars back, and Eli Lilly sends a welcome signal on its growth prospects

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Citi restarts coverage of Eli Lilly with Buy rating on increased tirzepatide forecasts By Investing.com

Citi restarts coverage of Eli Lilly with Buy rating on increased tirzepatide forecasts…

6 Incredible Reasons to Invest in Eli Lilly

The drug giants winning ways look set to continue for a while.…

Here are Fridays biggest analyst calls: Nvidia, Netflix, Tesla, Kroger, Arm, Oracle, Eli Lilly, PNC, GE Vernova & more

Here are Fridays biggest calls on Wall Street.…

Eli Lilly doubles down on Irish operations with $1.8 bln Investment By Investing.com

Eli Lilly doubles down on Irish operations with $1.8 bln Investment…

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimers drugs

Demand for Eli Lillys Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily…

Eli Lilly and Hertz Global have been highlighted as Zacks Bull and Bear of the Day

Eli Lilly and Hertz Global have been highlighted as Zacks Bull and Bear of the Day.…

Lilly expands manufacturing footprint in Ireland with $1.8 billion investment | Eli Lilly and Company

The Investor Relations website contains information about Eli Lilly and Companys business for stockholders, potential investors, and financial analysts.…

Bull of the Day: Eli Lilly (LLY)

Eli Lilly stock boasts both defensive and growth characteristics…

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: Im Not Talking About Zepbound)

Theres a little appreciated reason to own Eli Lilly stock, and it has nothing to do with its medicines.…

Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval - Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The…

Eli Lilly appoints insider Lucas Montarce as new finance chief

U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective…

This Unstoppable Stock Has Gained 100,203% Over The Last 50 Years, Creating Many Millionaires in the Process. Here Are 3 Reasons I Think It Will Continue to Create Generational Wealth.

Eli Lilly has been a big-time winner for investors over the last several decades, and there are many reasons to…

Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly

This drugmaker should have a basketful of growth drivers over the next decade.…

Stock Of The Day: Heres Why Weight-Loss Drug Maker Eli Lilly Has Reversed

…

This Big Move by Eli Lilly May Solve the Weight Loss Drug Markets Biggest Problem @themotleyfool #stocks $LLY

The weight loss drug market may soon be worth $100 billion.…

This Big Move by Eli Lilly May Solve the Weight Loss Drug Markets Biggest Problem

The weight loss drug market may soon be worth $100 billion.…

Eli Lillys Weekly Insulin Shot Meets Two Late-Stage Study Goals

Data from two late-stage studies show that LLYs once-weekly insulin injections achieved results that are similar to daily insulin shots.…

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile, Abbott launches its first over-the-counter…

Eli Lilly bets $409M for AI-focused drug discovery

…

Uber, Eli Lilly and 9 other stocks are added to BofAs Top Picks list By Investing.com

Uber, Eli Lilly and 9 other stocks are added to BofAs Top Picks list…

Eli Lilly Just Made Zepbound Even More Appealing. Heres What Smart Investors Need to Know.

Lilly just lowered the price of Zepbound.…

QIAGEN Stock Likely to Gain on Collaboration for APOE Genotyping

QGEN collaborates with Eli Lilly to develop a QIAstat-Dx IVD panel for APOE genotyping.…

Eli Lilly: Zepbound Price Cuts Have Multiple Positives, Limited Downside

…

Eli Lilly partner BioAge files for US IPO By Reuters

Eli Lilly partner BioAge files for US IPO…

Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain By Reuters

Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain…

Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain

…

S&P 500 Giants Meta, Eli Lilly Lead 5 Stocks Near Buy Points

While the Nasdaq lagged last week, the S&P 500 entered a power trend Friday.…

Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your Mind @themotleyfool #stocks $LLY

Eli Lilly may not be an expensive stock when you consider its long-run growth prospects.…

Why Hims & Hers Health Stock Was Falling This Week

A new threat from Eli Lilly pushed the stock lower.…

Why Hims & Hers Health Stock Was Falling This Week

A new threat from Eli Lilly pushed the stock lower.…

Why Hims & Hers Health Stock Was Falling This Week

A new threat from Eli Lilly pushed the stock lower.…

ROUNDUP 2/Dank Abnehmmittel: Eli Lilly erhöht Jahresziele erneut - Kurssprung

INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Eli Lilly hat im zweiten Quartal einen Umsatz- und Ergebnissprung…

Eli Lilly erhöht Jahresziele - Abnehmmittel treiben Geschäfte - Kurssprung

INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Eli Lilly hat im zweiten Quartal einen Umsatz- und Ergebnissprung…

Eli Lilly kann in USA mit Alzheimer-Medikament bei Beratergremium punkten

WHITE OAK/INDIANAPOLIS (dpa-AFX) - Der US-Arzneimittelhersteller Eli Lilly kann weiter auf eine Zulassung seines Alzheimermittels…

Eli Lilly erhöht Jahresziele - Abnehmmittel treibt Geschäfte - Kurssprung

INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Eli Lilly ist dank gut laufender Geschäfte mit Abnehmmitteln mit…

Pharmafirma Cheplapharm mit Rekordumsatz

GREIFSWALD (dpa-AFX) - Die Greifswalder Pharmafirma Cheplapharm ist weiter auf Wachstumskurs. Im Geschäftsjahr 2023 sei ein…

Zulassung von Lillys Alzheimer-Mittel könnte sich verzögern

INDIANAPOLS (dpa-AFX) - Der US-Arzneimittelhersteller Lilly muss womöglich noch länger auf eine Zulassung seines Alzheimermittels…

ANALYSE-FLASH: Jefferies hebt Ziel für Eli Lilly auf 853 Dollar - 'Buy'

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Eli Lilly nach…

ROUNDUP/Dank Abnehmmittel: Pharmakonzern Eli Lilly sieht weiteren Umsatzsprung

INDIANAPOLIS (dpa-AFX) - Nach dem Verkaufsstart seines Abnehmmittels traut sich der Pharmakonzern Eli Lilly 2024…

Dank Abnehmmittel: Pharmakonzern Eli Lilly sieht weiteren Umsatzsprung

INDIANAPOLIS (dpa-AFX) - Nach dem Verkaufsstart seines Abnehmmittels traut sich der Pharmakonzern Eli Lilly 2024…

AKTIE IM FOKUS: Studiendaten belasten Pharma-Schwergewicht Eli Lilly

NEW YORK (dpa-AFX) - Aktuelle Daten zum Abnehmmittel Zepbound (Tirzepatide) haben den in diesem Jahr bislang…

AKTIE IM FOKUS: Eli Lilly sehr schwach nach gutem Lauf und Studiendaten

NEW YORK (dpa-AFX Broker) - Die Aktien von Eli Lilly sind am Montag nach einem…

KORREKTUR 2: Pharmakonzern Eli Lilly investiert Milliarden in deutschen Standort

(Amt von Hernandez im ersten Absatz korrigiert) BERLIN (dpa-AFX) - Der US-Pharmakonzern…

KORREKTUR: Pharmakonzern Eli Lilly investiert Milliarden in deutschen Standort

(im ersten Satz des dritten Absatzes muss es korrekt Europa heißen. Zudem wurde ein Satz zu Abnehmspritzen…

Pharmakonzern Eli Lilly investiert Milliarden in deutschen Standort

BERLIN (dpa-AFX) - Der US-Pharmakonzern Eli Lilly will mit mehr als zwei Milliarden Euro eine…

Bericht: Pharmakonzern Eli Lilly plant Werk in Rheinland-Pfalz

MAINZ/ALZEY (dpa-AFX) - Der US-Pharmakonzern Eli Lilly plant einem Bericht zufolge einen Produktionsstandort in Rheinland-Pfalz.…

ROUNDUP: Pharmakonzern Eli Lilly floriert - Übernahmetour kostet aber Gewinn

INDIANAPOLIS (dpa-AFX) - Der Pharmakonzern Eli Lilly and Company wächst weiter rasant. Auch im vergangenen…